PRVL - Prevail Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $1.64. This is a potential upside of $1.64 (0%) from yesterday's end of day stock price of $0.

Prevail Therapeutics's activity chart (see below) currently has 16 price targets and 14 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 68% with an average time for these price targets to be met of 199.2 days.

Most recent stock forecast was given by LAURA CHICO from WEDBUSH on 22-Dec-2020. First documented stock forecast 14-Jul-2019.

Best performing analysts who are covering PRVL - Prevail Therapeutics:

Jeffrey Hung Laura Chico Christopher Raymond Paul Matteis Neena Bitritto-Garg

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$22

$-1 (-4.35%)

$22

4 years 10 months 2 days ago
(22-Dec-2020)

2/5 (40%)

$-1.18 (-5.09%)

234

Hold

$23

$23

4 years 10 months 8 days ago
(16-Dec-2020)

2/2 (100%)

$-0.17 (-0.73%)

84

Hold

$24

$1 (4.35%)

$24

4 years 10 months 10 days ago
(14-Dec-2020)

0/2 (0%)

$1.25 (5.49%)

Buy

5 years 2 months 14 days ago
(10-Aug-2020)

2/2 (100%)

$4.12 (25.94%)

241

Buy

$20

$-3 (-13.04%)

$20

5 years 9 months 28 days ago
(26-Dec-2019)

2/2 (100%)

$4.19 (26.50%)

437

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PRVL (Prevail Therapeutics) average time for price targets to be met?

On average it took 199.2 days on average for the stock forecasts to be realized with a an average price target met ratio 68

Which analyst has the current highest performing score on PRVL (Prevail Therapeutics) with a proven track record?

JEFFREY HUNG

Which analyst has the current lower performing score on PRVL (Prevail Therapeutics) with a proven track record?

NEENA BITRITTO-GARG

Which analyst has the most public recommendations on PRVL (Prevail Therapeutics)?

Jeffrey Hung has 6 price targets and 7 ratings on PRVL

Which analyst is the currently most bullish on PRVL (Prevail Therapeutics)?

Neena Bitritto-Garg with highest potential upside - $1

Which analyst is the currently most reserved on PRVL (Prevail Therapeutics)?

Jeffrey Hung with lowest potential downside - -$3

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?